|
|
|
|
|
|
|
|
|
02.02.26 - 22:06
|
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 (Business Wire)
|
|
|
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Monday, February 23, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.
The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year.
Upcoming Conference Participation
Hims & Hers also announced that members of the company's management team will be participating in the Morgan Stanley Technology, Media & Telecom Conference on March 2, 2026 in San Francisco.
About Hims & Hers Health, Inc.
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power o...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.01.26 - 11:12
|
Hims & Hers Aktie: Achtung, Gegenwind! (Aktiencheck)
|
|
|
New York (www.aktiencheck.de) - Hims & Hers-Aktienanalyse der Citigroup:
Citi gehe davon aus, dass die heutige Ankündigung von Novo Nordisk , wonach die Abnehm-Pille Wegovy nun in den gesamten USA breit verfügbar sei, Druck auf Hims & Hers (ISIN: US4330001060, WKN: A2QMYY, Ticker-Symbol: 82W, NYSE-Symbol: HIMS) ausüben werde. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
